Avidity Partners Management »

Jade Biosciences shares owned by Avidity Partners Management

Quarter-by-quarter ownership of Jade Biosciences (JBIO) shares owned by Avidity Partners Management from 13F filings

Historical chart of Avidity Partners Management investment in Jade Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Jade Biosciences held by Avidity Partners Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Jade Biosciences by Avidity Partners Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $9.7M 1.1M 8.63
2025-06-30 $11M 1.1M 9.99

More positions owned by Avidity Partners Management

Dianthus Therapeutics (DNTH)
Cg Oncology (CGON)
Medtronic SHS (MDT)
Boston Scientific Corporation (BSX)
Oruka Therapeutics (ORKA)
Bristol Myers Squibb (BMY)
Natera (NTRA)
Danaher Corporation (DHR)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Perspective Therapeutics Com New (CATX)
Jade Biosciences Com New (JBIO)
Pfizer (PFE)
Thermo Fisher Scientific (TMO)
Context Therapeutics (CNTX)
Genmab A/s Sponsored Ads (GMAB)

View all positions for Avidity Partners Management

Top funds holding Jade Biosciences

FMR
Fairmount Funds Management
VR Adviser
Deep Track Capital
BlackRock
Vanguard Group
Versant Venture Management
Rtw Investments
Frazier Life Sciences Management
Driehaus Capital Management
Avidity Partners Management
RA Capital Management
Soleus Capital Management
Geode Capital Management
Dr. Jeffrey R. Jay, M.D.

View all funds holding Jade Biosciences